Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psilocybin for Pain in Fibromyalgia
NCT06368492Recruiting
- Sponsor
- Maastricht University
- Start
- May 2024
- Primary completion
- Dec 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of psilocybin in fibromyalgia (FM), sponsored by Maastricht University. Primary endpoints: Ischemic Pain perception at 4 hours, Pressure-evoked Pain perception at 4 hours and 1 more. Started May 2024; status: recruiting.
02
Drugs
psilocybin
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT06368492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06368492.